Thyroid & Endocrine Health Panel
The Thyroid and Endocrine Panel provides vital genetic insights into both neoplastic risks (such as familial Medullary Thyroid Carcinoma) and inherited autoimmune pathways underlying Hashimoto’s disease and Graves’ ophthalmopathy. Accurate profiling empowers physicians to personalize surveillance and hormone balance protocols.
Check If You Qualify
Takes under 2 minutes • 100% Covered under Medicare Part B
Who Should Consider This Screening?
Healthcare providers recommend this diagnostic panel for individuals with the following personal or family health indicators:
Biomarkers & Genes Evaluated in this Panel
Processed using high-complexity Next-Generation Sequencing (NGS) in CLIA-certified and CAP-accredited partner laboratories.
| Gene Symbol / Name | Clinical Significance | Actionable Impact |
|---|---|---|
| RETProto-Oncogene Tyrosine Kinase Receptor | The definitive genetic driver of Multiple Endocrine Neoplasia Type 2 (MEN2) and familial Medullary Thyroid Cancer. | Guides life-saving prophylactic surgical timing, calcitonin monitoring, and targeted RET kinase inhibitor therapy. |
| MEN1Menin Tumor Suppressor | Regulates parathyroid, anterior pituitary, and pancreatic neuroendocrine cell proliferation. | Directs annual calcium/PTH blood testing and specialized endocrine MRI surveillance. |
| TSHR & TGThyrotropin Receptor & Thyroglobulin | Governs thyroid hormone synthesis, congenital dyshormonogenesis, and autoimmune receptor reactivity. | Assists endocrinologists in fine-tuning synthetic levothyroxine / T3 combination dosing protocols. |
Sample Report & Diagnostic Action Plan
Every patient receives an easy-to-understand diagnostic summary and a detailed clinical report tailored for their primary care doctor.
No pathogenic variants detected in RET, MEN1, or primary endocrine malignancy loci.
Routine annual TSH/Free T4 monitoring with primary care physician; standard thyroid ultrasound management as clinically indicated.
Medicare Part B Coverage Guidelines
Understand how federal CMS medical necessity guidelines apply to this specific diagnostic screening:
Covered under Medicare Part B when ordered by a licensed physician for evaluation of suspected familial thyroid malignancy or complex endocrine disorders.
Ready to Check Your Eligibility for Thyroid & Endocrine Health Panel?
Takes under 2 minutes • Painless at-home cheek swab • 100% Physician Reviewed